These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30305500)

  • 1. [Molecular pathophysiology of sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2024; 65(9):911-919. PubMed ID: 39358290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Pediatr Int; 2013 Dec; 55(6):675-9. PubMed ID: 24003969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ring sideroblasts and iron metabolism].
    Fujiwara T
    Rinsho Ketsueki; 2020; 61(7):770-778. PubMed ID: 32759564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in the knowledge of sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2022; 63(6):600-607. PubMed ID: 35831194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology of sideroblastic anemia].
    Harigae H
    Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sideroblastic anemia].
    Fujiwara T
    Rinsho Ketsueki; 2019; 60(5):408-416. PubMed ID: 31168006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary sideroblastic anemia: pathophysiology and gene mutations.
    Harigae H; Furuyama K
    Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
    Camaschella C
    Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
    Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
    Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial iron metabolism and sideroblastic anemia.
    Sheftel AD; Richardson DR; Prchal J; Ponka P
    Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and gene mutation spectrum in children with sideroblastic anemia].
    An WB; An WB; Liu C; Wan Y; Guo Y; Wang SC; Zhang YC; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Oct; 21(10):1016-1021. PubMed ID: 31642437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.
    Saito K; Fujiwara T; Hatta S; Morita M; Ono K; Suzuki C; Fukuhara N; Onishi Y; Nakamura Y; Kawamata S; Shimizu R; Yamamoto M; Harigae H
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
    Bhatia P; Singh A; Hedge A
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
    Ono K; Fujiwara T; Saito K; Nishizawa H; Takahashi N; Suzuki C; Ochi T; Kato H; Ishii Y; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Yamada R; Nakamura Y; Igarashi K; Harigae H
    Sci Rep; 2022 May; 12(1):9024. PubMed ID: 35637209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.